Patents Assigned to UrSure, Inc.
  • PRODUCTS AND METHODS FOR MONITORING ADHERENCE TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY
    Publication number: 20200239598
    Abstract: The invention provides novel compounds, reagents, systems, and methods for detecting a metabolite related to a NRTI in a biological sample, and use thereof in monitoring adherence to pre-exposure prophylaxis or anti-retroviral treatment. Such reagents comprise NRTI derivatives, analogs, NRTI derivatives conjugates, along with antibodies directed to same, which are useful for anti-body-based methods, such as a lateral flow immunoassay and other point of care devices.
    Type: Application
    Filed: October 15, 2018
    Publication date: July 30, 2020
    Applicant: UrSure, Inc.
    Inventors: Giffin Daughtridge, Keith Kardos
  • SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
    Publication number: 20200200735
    Abstract: The invention provides methods and systems for detecting a metabolite related to a NRTI in a biological sample, and use thereof in monitoring adherence to pre-exposure prophylaxis. The metabolite can be identified using proteomic methods, including but not limited to antibody based methods, such as a lateral flow immunoassay or lab based assays such as semi-quantitative LC-MS/MS.
    Type: Application
    Filed: February 22, 2017
    Publication date: June 25, 2020
    Applicant: UrSure, Inc.
    Inventors: Helen Koenig, Giffin Daughtridge, Keith Kardos